Nutrition, insulin-like growth factor-1 and retinopathy of prematurity

Seminars in Fetal and Neonatal Medicine

Volumn 18, Issue 3, 2013, Pages 136-142

  Hård, Anna Lena ^a   Smith, Lois E ^b   Hellström, Ann ^a  

^a QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

IGF 1; Nutrition; Omega 3; Retinopathy of prematurity

Indexed keywords

ALPHA TOCOPHEROL; AMINO ACID; DOCOSAHEXAENOIC ACID; INOSITOL; INTRALIPID; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYUNSATURATED FATTY ACID; SOMATOMEDIN C;

ALGORITHM; ANGIOGENESIS; APOPTOSIS; ARTIFICIAL MILK; BREAST MILK; DIET SUPPLEMENTATION; GROWTH RETARDATION; HUMAN; HYPOXIA; INTRAUTERINE GROWTH RETARDATION; METABOLIC RATE; NEWBORN; NONHUMAN; NUTRIENT; NUTRITION; OXIDATIVE STRESS; OXYGEN THERAPY; PARENTERAL NUTRITION; PHASE 2 CLINICAL TRIAL (TOPIC); PHOTORECEPTOR; POSTNATAL GROWTH; PREMATURITY; RETINA BLOOD VESSEL; RETINOPATHY; RETROLENTAL FIBROPLASIA; REVIEW; SCREENING; VASCULARIZATION;

EID: 84892432494     PISSN: 1744165X     EISSN: 18780946     Source Type: Journal    
DOI: 10.1016/j.siny.2013.01.006     Document Type: Review

References (92)

1. Garner A., Ashton N. Vaso-obliteration and retrolental fibroplasia. Proc R Soc Med 1971, 64:774-777.
2. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005, 123:991-999. International Committee for the Classification of Retinopathy of Prematurity.
3. Sun Y., Dalal R., Gariano R.F. Cellular composition of the ridge in retinopathy of prematurity. Arch Ophthalmol 2010, 128:638-641.
4. Joyal J.S., Sitaras N., Binet F., et al. Ischemic neurons prevent vascular regeneration of neural tissue by secreting semaphorin 3A. Blood 2011, 117:6024-6035.
5. Kajantie E., Dunkel L., Rutanen E.M., et al. IGF-I, IGF binding protein (IGFBP)-3, phosphoisoforms of IGFBP-1, and postnatal growth in very low birth weight infants. JClin Endocrinol Metab 2002, 87:2171-2179.
6. Jones J.I., D'Ercole A.J., Camacho-Hubner C., Clemmons D.R. Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and invivo: effects on affinity for IGF-I. Proc Natl Acad Sci U S A 1991, 88:7481-7485.
7. Kielczewski J.L., Hu P., Shaw L.C., et al. Novel protective properties of IGFBP-3 result in enhanced pericyte ensheathment, reduced microglial activation, increased microglial apoptosis, and neuronal protection after ischemic retinal injury. Am J Pathol 2011, 178:1517-1528.
8. Kielczewski J.L., Jarajapu Y.P., McFarland E.L., et al. Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation. Circ Res 2009, 105:897-905.
9. Lassarre C., Hardouin S., Daffos F., Forestier F., Frankenne F., Binoux M. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res 1991, 29:219-225.
10. Netchine I., Azzi S., Le Bouc Y., Savage M.O. IGF1 molecular anomalies demonstrate its critical role in fetal, postnatal growth and brain development. Best Pract Res Clin Endocrinol Metab 2011, 25:181-190.
11. Liu J.P., Baker J., Perkins A.S., Robertson E.J., Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993, 75:59-72.
12. Baker J., Liu J.P., Robertson E.J., Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993, 75:73-82.
13. Sjogren K., Liu J.L., Blad K., et al. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci U S A 1999, 96:7088-7092.
14. Stratikopoulos E., Szabolcs M., Dragatsis I., Klinakis A., Efstratiadis A. The hormonal action of IGF1 in postnatal mouse growth. Proc Natl Acad Sci U S A 2008, 105:19378-19383.
15. Yakar S., Rosen C.J., Beamer W.G., et al. Circulating levels of IGF-1 directly regulate bone growth and density. JClin Invest 2002, 110:771-781.
16. Bach M.A., Shen-Orr Z., Lowe W.L., Roberts C.T., LeRoith D. Insulin-like growth factor I mRNA levels are developmentally regulated in specific regions of the rat brain. Brain Res Mol Brain Res 1991, 10:43-48.
17. Nishijima T., Piriz J., Duflot S., et al. Neuronal activity drives localized blood-brain-barrier transport of serum insulin-like growth factor-I into the CNS. Neuron 2010, 67:834-846.
18. Cheng C.M., Reinhardt R.R., Lee W.H., Joncas G., Patel S.C., Bondy C.A. Insulin-like growth factor 1 regulates developing brain glucose metabolism. Proc Natl Acad Sci U S A 2000, 97:10236-10241.
19. Torres-Aleman I. Toward a comprehensive neurobiology of IGF-I. Dev Neurobiol 2010, 70:384-396.
20. Langford K., Nicolaides K., Miell J.P. Maternal and fetal insulin-like growth factors and their binding proteins in the second and third trimesters of human pregnancy. Hum Reprod 1998, 13:1389-1393.
21. Chu Y., Hughes S., Chan-Ling T. Differentiation and migration of astrocyte precursor cells and astrocytes in human fetal retina: relevance to optic nerve coloboma. FASEB J 2001, 15:2013-2015.
22. Chan-Ling T., McLeod D.S., Hughes S., et al. Astrocyte-endothelial cell relationships during human retinal vascular development. Invest Ophthalmol Vis Sci 2004, 45:2020-2032.
23. Stone J., Itin A., Alon T., et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. JNeurosci 1995, 15(7 Pt 1):4738-4747.
24. Hellström A., Perruzzi C., Ju M., et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A 2001, 98:5804-5808.
25. Nowak D.G., Amin E.M., Rennel E.S., et al. Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis. JBiol Chem 2010, 285:5532-5540.
26. Smith L.E., Wesolowski E., McLellan A., et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994, 35:101-111.
27. Lubchenco L.O., Boyd E., Dressler M.S. Growth of prematurely born infants with and without retrolental fibroplasia. Am J Dis Child 1953, 86:466-468.
28. Hellström B.E. Experimental approach to the pathogenesis of retrolental fibroplasia. V. The influence of the state of nutrition on oxygen-induced changes in the mouse eye. Acta Paediatr 1956, 45:43-57.
29. Reynaud X., Dorey C.K. Extraretinal neovascularization induced by hypoxic episodes in the neonatal rat. Invest Ophthalmol Vis Sci 1994, 35:3169-3177.
30. Penn J.S., Tolman B.L., Lowery L.A. Variable oxygen exposure causes preretinal neovascularization in the newborn rat. Invest Ophthalmol Vis Sci 1993, 34:576-585.
31. Zhang S., Leske D.A., Lanier W.L., Holmes J.M. Postnatal growth retardation exacerbates acidosis-induced retinopathy in the neonatal rat. Curr Eye Res 2001, 22:133-139.
32. Stahl A., Chen J., Sapieha P., et al. Postnatal weight gain modifies severity and functional outcome of oxygen-induced proliferative retinopathy. Am J Pathol 2010, 177:2715-2723.
33. Vanhaesebrouck S., Daniels H., Moons L., Vanhole C., Carmeliet P., De Zegher F. Oxygen-induced retinopathy in mice: amplification by neonatal IGF-I deficit and attenuation by IGF-I administration. Pediatr Res 2009, 65:307-310.
34. Fryklund L, Gluckman P, Skottner A. Treatment of catabolic states using authentic IGF-I and hypocaloric amount of nutrients. United States Patent Number 6,034,059; published 7 March 2000.
35. Cooke R.J., Ainsworth S.B., Fenton A.C. Postnatal growth retardation: a universal problem in preterm infants. Arch Dis Child Fetal Neonatal Ed 2004, 89:F428-F430.
36. Hall J.G., Freedman S.F., Kylstra J.A. Clinical course and systemic correlates of retinopathy of prematurity in quintuplets. Am J Ophthalmol 1995, 119:658-660.
37. Wallace D.K., Kylstra J.A., Phillips S.J., Hall J.G. Poor postnatal weight gain: a risk factor for severe retinopathy of prematurity. JAAPOS 2000, 4:343-347.
38. Allegaert K., Vanhole C., Casteels I., et al. Perinatal growth characteristics and associated risk of developing threshold retinopathy of prematurity. JAAPOS 2003, 7:34-37.
39. Fortes Filho J.B., Bonomo P.P., Maia M., Procianoy R.S. Weight gain measured at 6 weeks after birth as a predictor for severe retinopathy of prematurity: study with 317 very low birth weight preterm babies. Graefes Arch Clin Exp Ophthalmol 2009, 247:831-836.
40. Incidence of and risk factors for neonatal morbidity after active perinatal care: extremely preterm infants study in Sweden (EXPRESS). Acta Paediatr 2010, 99:978-992. EXPRESS Group.
41. Hellström A., Engström E., Hård A.L., et al. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics 2003, 112:1016-1020.
42. Löfqvist C., Hansen-Pupp I., Andersson E., et al. Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I. Arch Ophthalmol 2009, 127:622-627.
43. Löfqvist C., Andersson E., Sigurdsson J., et al. Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity. Arch Ophthalmol 2006, 124:1711-1718.
44. Wu C., Vanderveen D.K., Hellström A., Löfqvist C., Smith L.E. Longitudinal postnatal weight measurements for the prediction of retinopathy of prematurity. Arch Ophthalmol 2010, 128:443-447.
45. Hard A.L., Löfqvist C., Fortes Filho J.B., Procianoy R.S., Smith L., Hellström A. Predicting proliferative retinopathy in a Brazilian population of preterm infants with the screening algorithm WINROP. Arch Ophthalmol 2010, 128:1432-1436.
46. Fluckiger S., Bucher H.U., Hellström A., Löfqvist C., Sturm V., Arri S.J. The early postnatal weight gain as a predictor of retinopathy of prematurity. Klin Monbl Augenheilkd 2011, 228:306-310.
47. Wu C., Löfqvist C., Smith L.E., Vanderveen D.K., Hellström A. Importance of early postnatal weight gain for normal retinal angiogenesis in very preterm infants: a multicenter study analyzing weight velocity deviations for the prediction of retinopathy of prematurity. Arch Ophthalmol 2012.
48. Zepeda-Romero L.C., Hård A.L., Gomez-Ruiz L.M., et al. Prediction of retinopathy of prematurity using the screening algorithm WINROP in a Mexican population of preterm infants. Arch Ophthalmol 2012, 130:720-723.
49. Martin C.R., Brown Y.F., Ehrenkranz R.A., et al. Nutritional practices and growth velocity in the first month of life in extremely premature infants. Pediatrics 2009, 124:649-657.
50. Ehrenkranz R.A., Younes N., Lemons J.A., et al. Longitudinal growth of hospitalized very low birth weight infants. Pediatrics 1999, 104(2 Pt 1):280-289.
51. Singer D., Muhlfeld C. Perinatal adaptation in mammals: the impact of metabolic rate. Comp Biochem Physiol A Mol Integr Physiol 2007, 148:780-784.
52. Kurzner S.I., Garg M., Bautista D.B., et al. Growth failure in infants with bronchopulmonary dysplasia: nutrition and elevated resting metabolic expenditure. Pediatrics 1988, 81:379-384.
53. Underwood M.A., Gilbert W.M., Sherman M.P. Amniotic fluid: not just fetal urine anymore. JPerinatol 2005, 25:341-348.
54. Burjonrappa S.C., Crete E., Bouchard S. The role of amniotic fluid in influencing neonatal birth weight. JPerinatol 2010, 30:27-29.
55. Neu J. Gastrointestinal development and meeting the nutritional needs of premature infants. Am J Clin Nutr 2007, 85:629S-634S.
56. Martinez M., Ballabriga A. Achemical study on the development of the human forebrain and cerebellum during the brain 'growth spurt' period. I. Gangliosides and plasmalogens. Brain Res 1978, 159:351-362.
57. Clandinin M.T., Chappell J.E., Leong S., Heim T., Swyer P.R., Chance G.W. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev 1980, 4:121-129.
58. Brenna J.T. Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man. Curr Opin Clin Nutr Metab Care 2002, 5:127-132.
59. Salem N., Wegher B., Mena P., Uauy R. Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants. Proc Natl Acad Sci U S A 1996, 93:49-54.
60. Uauy R., Dangour A.D. Nutrition in brain development and aging: role of essential fatty acids. Nutr Rev 2006, 64(5 Pt 2):S24-S33. discussion S72-91.
61. German O.L., Insua M.F., Gentili C., Rotstein N.P., Politi L.E. Docosahexaenoic acid prevents apoptosis of retina photoreceptors by activating the ERK/MAPK pathway. JNeurochem 2006, 98:1507-1520.
62. Martin C.R., Dasilva D.A., Cluette-Brown J.E., et al. Decreased postnatal docosahexaenoic and arachidonic acid blood levels in premature infants are associated with neonatal morbidities. JPediatr 2011, 159:743-749. e1-2.
63. Connor K.M., SanGiovanni J.P., Löfqvist C., et al. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med 2007, 13:868-873.
64. Sapieha P., Stahl A., Chen J., et al. 5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of ω-3 polyunsaturated fatty acids. Sci Transl Med 2011, 3:69ra12.
65. Stahl A., Sapieha P., Connor K.M., et al. Short communication: PPAR gamma mediates a direct antiangiogenic effect of omega 3-PUFAs in proliferative retinopathy. Circ Res 2010, 107:495-500.
66. Pawlik D., Lauterbach R., Turyk E. Fish-oil fat emulsion supplementation may reduce the risk of severe retinopathy in VLBW infants. Pediatrics 2011, 127:223-228.
67. Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. JPediatr 1992, 120(4 Pt 2):S129-S138.
68. Gobel Y., Koletzko B., Bohles H.J., et al. Parenteral fat emulsions based on olive and soybean oils: a randomized clinical trial in preterm infants. JPediatr Gastroenterol Nutr 2003, 37:161-167.
69. Koletzko B., Rodriguez-Palmero M. Polyunsaturated fatty acids in human milk and their role in early infant development. JMammary Gland Biol Neoplasia 1999, 4:269-284.
70. Buts J.P. Bioactive factors in milk. Arch Pediatr 1998, 5:298-306.
71. Baxter R.C., Zaltsman Z., Turtle J.R. Immunoreactive somatomedin-C/insulin-like growth factor I and its binding protein in human milk. JClin Endocrinol Metab 1984, 58:955-959.
72. Vanhaesebrouck S., Vanhole C., de Zegher F., Allegaert K. Influence of duration of parenteral nutrition on retinopathy of prematurity. Arch Dis Child Fetal Neonatal Ed 2008, 93:F170.
73. Porcelli P.J., Weaver R.G. The influence of early postnatal nutrition on retinopathy of prematurity in extremely low birth weight infants. Early Hum Dev 2010, 86:391-396.
74. Okamoto T., Shirai M., Kokubo M., et al. Human milk reduces the risk of retinal detachment in extremely low-birthweight infants. Pediatr Int 2007, 49:894-897.
75. Maayan-Metzger A., Avivi S., Schushan-Eisen I., Kuint J. Human milk versus formula feeding among preterm infants: short-term outcomes. Am J Perinatol 2012, 29:121-126.
76. Hylander M.A., Strobino D.M., Pezzullo J.C., Dhanireddy R. Association of human milk feedings with a reduction in retinopathy of prematurity among very low birthweight infants. JPerinatol 2001, 21:356-362.
77. Heller C.D., O'Shea M., Yao Q., et al. Human milk intake and retinopathy of prematurity in extremely low birth weight infants. Pediatrics 2007, 120:1-9.
78. Friedman C.A., McVey J., Borne M.J., et al. Relationship between serum inositol concentration and development of retinopathy of prematurity: a prospective study. JPediatr Ophthalmol Strabismus 2000, 37:79-86.
79. Cavalli C., Teng C., Battaglia F.C., Bevilacqua G. Free sugar and sugar alcohol concentrations in human breast milk. JPediatr Gastroenterol Nutr 2006, 42:215-221.
80. Carver J.D., Stromquist C.I., Benford V.J., Minervini G., Benford S.A., Barness L.A. Postnatal inositol levels in preterm infants. JPerinatol 1997, 17:389-392.
81. Howlett A., Ohlsson A., Plakkal N. Inositol for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 2012, 3. CD000366.
82. Owens W.C., Owens E.U. Retrolental fibroplasia in premature infants; studies on the prophylaxis of the disease; the use of alpha tocopheryl acetate. Am J Ophthalmol 1949, 32:1631-1637.
83. Brion L.P., Bell E.F., Raghuveer T.S. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2003, 4. CD003665.
84. York J.R., Landers S., Kirby R.S., Arbogast P.G., Penn J.S. Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants. JPerinatol 2004, 24:82-87.
85. Coleman R.J., Beharry K.D., Brock R.S., Abad-Santos P., Abad-Santos M., Modanlou H.D. Effects of brief, clustered versus dispersed hypoxic episodes on systemic and ocular growth factors in a rat model of oxygen-induced retinopathy. Pediatr Res 2008, 64:50-55.
86. Can E., Bülbül A., Uslu S., Cömert S., Bolat F., Nuhoǧlu A. Effects of aggressive parenteral nutrition on growth and clinical outcome in preterm infants. Pediatr Int 2012, 54:869-874.
87. Hansen-Pupp I., Löfqvist C., Polberger S., et al. Influence of insulin-like growth factor I and nutrition during phases of postnatal growth in very preterm infants. Pediatr Res 2011, 69(5 Pt 1):448-453.
88. Kaempf J.W., Kaempf A.J., Wu Y., Stawarz M., Niemeyer J., Grunkemeier G. Hyperglycemia, insulin and slower growth velocity may increase the risk of retinopathy of prematurity. JPerinatol 2011, 31:251-257.
89. Garg R., Agthe A.G., Donohue P.K., Lehmann C.U. Hyperglycemia and retinopathy of prematurity in very low birth weight infants. JPerinatol 2003, 23:186-194.
90. Ertl T., Gyarmati J., Gaal V., Szabo I. Relationship between hyperglycemia and retinopathy of prematurity in very low birth weight infants. Biol Neonate 2006, 89:56-59.
91. Blanco C.L., Baillargeon J.G., Morrison R.L., Gong A.K. Hyperglycemia in extremely low birth weight infants in a predominantly Hispanic population and related morbidities. JPerinatol 2006, 26:737-741.
92. Ley D., Hansen-Pupp I., Niklasson A., et al. Longitudinal infusion of a complex of insulin-like growth factor-I and IGF-binding protein-3 in five preterm infants: pharmacokinetics and short-term safety. Pediatr Res 2013, 73:68-74.